Authors
Loading...
This review discusses solid dispersion technology's role in enhancing oral bioavailability of poorly soluble APIs, highlighting recent advancements and implications.
Rajaram et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: